Aurora Cannabis Inc (TSE:ACB)’s share price rose 4.8% on Friday . The company traded as high as C$8.32 and last traded at C$8.15, approximately 1,934,811 shares changed hands during trading. A decline of 82% from the average daily volume of 10,888,536 shares. The stock had previously closed at C$7.78.
ACB has been the subject of a number of recent research reports. Desjardins reaffirmed a “buy” rating and set a C$16.50 price objective on shares of Aurora Cannabis in a research report on Friday, April 26th. Jefferies Financial Group increased their price objective on Aurora Cannabis from C$12.00 to C$14.00 in a research report on Friday, May 3rd. Finally, Bank of America reaffirmed a “buy” rating and set a C$15.00 price objective on shares of Aurora Cannabis in a research report on Wednesday, April 17th. One analyst has rated the stock with a hold rating and five have given a buy rating to the company. The company presently has a consensus rating of “Buy” and a consensus price target of C$14.58.
The company has a debt-to-equity ratio of 14.55, a current ratio of 2.37 and a quick ratio of 1.80. The firm’s fifty day moving average is C$9.43. The firm has a market capitalization of $7.88 billion and a price-to-earnings ratio of -31.67.
About Aurora Cannabis (TSE:ACB)
Aurora Cannabis Inc produces and distributes medical cannabis products. It is vertically integrated and horizontally diversified across various segments of the cannabis value chain, from facility engineering and design to cannabis breeding, genetics research, production, derivatives, high value-add product development, home cultivation, wholesale, and retail distribution.
Featured Article: Risk Tolerance
Receive News & Ratings for Aurora Cannabis Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Aurora Cannabis and related companies with MarketBeat.com's FREE daily email newsletter.